TRIM25 Degrades BRD7 Protein Stability through the Ubiquitin Proteasome Pathway to Promote Breast Cancer Progression and Paclitaxel Resistance by Activating YB1/Bcl-2 Transcription Axis
Investigators revealed that TRIM25 effectively promoted cell proliferation, cell cycle progression, and paclitaxel chemoresistance of breast cancer cells.